Equifax Inc. (NYSE:EFX – Get Free Report) EVP Lisa M. Nelson sold 551 shares of the stock in a transaction that occurred on Tuesday, November 26th. The shares were sold at an average price of $260.39, for a total transaction of $143,474.89. Following the completion of the transaction, the executive vice president now directly owns 11,697 shares of the company’s stock, valued at $3,045,781.83. The trade was a 4.50 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink.
Equifax Price Performance
Shares of NYSE:EFX traded up $2.45 during trading on Wednesday, reaching $261.39. The stock had a trading volume of 559,248 shares, compared to its average volume of 876,628. Equifax Inc. has a 1-year low of $209.68 and a 1-year high of $309.63. The stock has a market cap of $32.40 billion, a PE ratio of 58.09, a PEG ratio of 3.28 and a beta of 1.59. The business has a fifty day moving average price of $276.01 and a 200-day moving average price of $268.48. The company has a debt-to-equity ratio of 0.96, a quick ratio of 0.88 and a current ratio of 0.88.
Equifax (NYSE:EFX – Get Free Report) last posted its quarterly earnings results on Wednesday, October 16th. The credit services provider reported $1.85 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.84 by $0.01. The business had revenue of $1.44 billion during the quarter, compared to analyst estimates of $1.44 billion. Equifax had a return on equity of 18.56% and a net margin of 10.07%. The business’s revenue was up 9.3% compared to the same quarter last year. During the same period in the prior year, the business earned $1.76 earnings per share. On average, equities analysts forecast that Equifax Inc. will post 7.27 earnings per share for the current fiscal year.
Equifax Dividend Announcement
Institutional Investors Weigh In On Equifax
Several hedge funds and other institutional investors have recently added to or reduced their stakes in the business. International Assets Investment Management LLC lifted its holdings in shares of Equifax by 76,913.8% in the 3rd quarter. International Assets Investment Management LLC now owns 960,362 shares of the credit services provider’s stock worth $282,212,000 after acquiring an additional 959,115 shares during the last quarter. FMR LLC boosted its stake in shares of Equifax by 37.4% in the third quarter. FMR LLC now owns 3,233,744 shares of the credit services provider’s stock valued at $950,268,000 after purchasing an additional 880,162 shares during the period. Franklin Resources Inc. grew its holdings in shares of Equifax by 34.2% in the third quarter. Franklin Resources Inc. now owns 863,718 shares of the credit services provider’s stock valued at $251,480,000 after purchasing an additional 220,109 shares in the last quarter. Massachusetts Financial Services Co. MA increased its position in shares of Equifax by 4.9% during the second quarter. Massachusetts Financial Services Co. MA now owns 4,276,798 shares of the credit services provider’s stock worth $1,036,952,000 after acquiring an additional 200,665 shares during the period. Finally, Ceredex Value Advisors LLC boosted its holdings in Equifax by 127.1% in the second quarter. Ceredex Value Advisors LLC now owns 350,356 shares of the credit services provider’s stock valued at $84,947,000 after purchasing an additional 196,106 shares during the period. Institutional investors and hedge funds own 96.20% of the company’s stock.
Analyst Upgrades and Downgrades
A number of equities research analysts have recently weighed in on EFX shares. BNP Paribas raised shares of Equifax from an “underperform” rating to a “neutral” rating and set a $310.00 price objective on the stock in a report on Thursday, September 19th. Oppenheimer dropped their target price on Equifax from $315.00 to $286.00 and set an “outperform” rating on the stock in a research report on Tuesday, November 19th. Robert W. Baird lifted their price objective on shares of Equifax from $290.00 to $333.00 and gave the company an “outperform” rating in a research note on Friday, October 18th. JPMorgan Chase & Co. lowered their price target on shares of Equifax from $304.00 to $283.00 and set an “overweight” rating on the stock in a report on Tuesday, November 19th. Finally, Morgan Stanley boosted their price objective on Equifax from $250.00 to $271.00 and gave the company an “equal weight” rating in a report on Thursday, September 12th. Four research analysts have rated the stock with a hold rating and fifteen have given a buy rating to the company’s stock. According to MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $306.74.
Read Our Latest Stock Report on EFX
About Equifax
Equifax Inc operates as a data, analytics, and technology company. The company operates through three segments: Workforce Solutions, U.S. Information Solutions (USIS), and International. The Workforce Solutions segment offers services that enables customers to verify income, employment, educational history, criminal justice data, healthcare professional licensure, and sanctions of people in the United States; and employer customers with services that assist them in complying with and automating payroll-related and human resource management processes throughout the entire cycle of the employment relationship.
Featured Articles
- Five stocks we like better than Equifax
- Pros And Cons Of Monthly Dividend Stocks
- Microsoft Stock Gets a $550 Price Target: Time to Get Excited
- 3 Grocery Stocks That Can Help Take a Bite Out of Inflation
- Trump Tariffs in Focus: 2 Chinese Stocks to Own and 2 to Avoid
- Consumer Staples Stocks, Explained
- 2 Generic Drug Stocks Ready to Surge in 2025
Receive News & Ratings for Equifax Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Equifax and related companies with MarketBeat.com's FREE daily email newsletter.